Data / Form D filings / AVEO PHARMACEUTICALS INC
AVEO PHARMACEUTICALS INC: Form D filings
AVEO PHARMACEUTICALS INC, a pharmaceuticals company in Cambridge, MA, filed 3 Form D notices with the SEC between 2009 and 2011. The latest, on May 31, 2011, reports $7.5 million sold of a $7.5 million offering to 1 investor.
Find out what AVEO PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 75 SIDNEY STREET, 4TH FLOOR, Cambridge, MA, 02139
- Phone
- (617) 299-5000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1325879
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 31, 2011 | New notice | $7,499,997 | $7,499,997 | $0 | 1 | May 31, 2011 | sec.gov |
| Nov 3, 2010 | New notice | $60,750,000 | $60,750,000 | $0 | 21 | Nov 3, 2010 | sec.gov |
| Apr 1, 2009 | New notice | $60,000,000 | $30,000,000 | $30,000,000 | 1 | Mar 18, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kenneth M. Bate | Director | |
| Nicholas Galakatos | Director | |
| Jeno Gyuris | Executive Officer | |
| Henri A. Termeer | Director | |
| Kenneth C. Weg | Director | |
| Ronald DePinho | Director | |
| Michael A. Bailey | Executive Officer | |
| William M. Slichenmyer | Executive Officer | |
| Douglas Cole | Director | |
| Raju C. Kucherlapati | Director | |
| David Johnston | Executive Officer | |
| Tuan Ha-Ngoc | Executive Officer, Director | |
| Elan M. Ezickson | Executive Officer | |
| Robert C. Young | Director | |
| Russell C. Hirsch | Director | |
| Anthony Evnin | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of May 30, 2011 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AVEO PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.